Company Filing History:
Years Active: 2003
Title: The Innovations of Charles Alexander Quinn
Introduction
Charles Alexander Quinn is a notable inventor based in Pascoe Vale, Australia. He has made significant contributions to the field of medical science, particularly in the treatment and prevention of infections caused by Helicobacter bacteria. His innovative work has led to the development of a unique antigenic preparation that holds promise for mammalian hosts.
Latest Patents
Quinn holds a patent for an "Antigenic preparation for treatment or prevention of Helicobacter infection." This patent describes an antigenic preparation that comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, specifically targeting the LPS of certain strains or an immunogenic fragment thereof. This invention aims to provide a new approach to combat Helicobacter infections effectively.
Career Highlights
Charles Quinn is associated with CSL Limited, a leading global biotechnology company. His work at CSL Limited has allowed him to focus on innovative solutions in the healthcare sector. With a patent portfolio that includes 1 patent, Quinn has established himself as a key figure in the development of medical treatments.
Collaborations
Throughout his career, Quinn has collaborated with esteemed colleagues, including Christopher Vincent Doidge and Adrian Lee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Charles Alexander Quinn's contributions to the field of medical science through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to inspire advancements in the treatment of Helicobacter infections, showcasing the importance of innovation in medicine.